Neopath files initial screening premarket approval application (PMA) for AutoPap
This article was originally published in Clinica
Executive Summary
Neopath (US) has filed a new PMA with the US FDA to allow its AutoPap slide reader to be used for initial cervical screening. The FDA's haematology and pathology devices panel will review the application - for initial screening of all Pap smear slides processed by a clinical laboratory - on September 27th.